Drugs / Xarlin
Xarlin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01062139 | Oct 2009 → Apr 2010 | perennial allergic rhinitis | HK inno.N Corporation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xarlin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01062139 ↗ |
| Known as | Levocetirizine | “Xarlin (Levocetirizine)” NCT01062139 ↗ |
| Known as | Levocetirizine HCl | “Xarlin Tab (Levocetirizine HCl)” NCT01062139 ↗ |